Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASSURE: Simplifying HIV Therapy to ATV + ABC/3TC
NCT01102972Phase 4Completed
- Sponsor
- ViiV Healthcare
- Start
- Apr 2010
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of abacavir, lamivudine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Started Apr 2010; status: completed.
02
Drugs
abacavirlamivudine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01102972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01102972.